Stock THAR THARIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Tharimmune, Inc.

Equities

THAR

US4327053090

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-20 pm EDT 		5-day change 1st Jan Change
3.13 USD +5.56% Intraday chart for Tharimmune, Inc. -6.29% -59.00%
Jun. 20 Tharimmune Prices $2.1 Million Private Placement of Common Shares, Warrants MT
Jun. 17 Tharimmune, Inc. Announces Positive Type C Meeting with FDA for Phase 2 Program for TH104, Its Lead Candidate for Moderate-To-Severe Pruritus in Primary Biliary Cholangitis CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
THARIMMUNE, INC.
Bio Therapeutic Drugs
+5.56%-6.29%-59.00%-97.66% - 2.33M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. THAR Stock
  4. Charts Tharimmune, Inc.
  5. Comparison Chart